AlloSource announces first patients implanted with AlloWrap Amniotic Membrane in clinical study for two-level anterior cervical discectomy and fusion procedures
CENTENNIAL -- AlloSource announced the first patients have been enrolled in its clinical study titled, "A Randomized, Controlled Study to Evaluate Effectiveness of AlloWrap Amniotic Membrane for... Read More
Thursday February 25, 2021
Essent Biologics launches to provide human-derived biomaterials and 3D biology data for cell therapy, tissue engineering
CENTENNIAL -- Essent Biologics today announced its launch as a new venture to meet the growing need for human-derived biomaterials and data to the regenerative medicine research community, as well... Read More
Wednesday January 27, 2021
Arrow Electronics names Sean J. Kerins chief operating officer
CENTENNIAL -- Arrow Electronics, Inc. (NYSE:ARW) announced Sean J. Kerins is the company’s new chief operating officer. He will continue to report to Michael J. Long , chairman, president and... Read More
Monday December 28, 2020
Science behind AlloSource Cryopreserved Cartilage published in med journal
CENTENNIAL -- AlloSource , one of the largest allograft providers in the U.S., announced the Journal of Orthopaedic Surgery and Research published the company's science in an article titled... Read More
Thursday December 10, 2020
AlloSource names tendon and ligament portfolio under AlloConnex brand
CENTENNIAL -- AlloSource announced it is naming its tendon and ligament portfolio under the new brand AlloConnex. "Over the past 25 years, our offering of tendons and ligaments has grown, and... Read More
Monday July 27, 2020
Laser Technology’s LaserSoft WorkSite app now available to download
CENTENNIAL -- Laser Technology, Inc. (LTI) released its free LaserSoft® WorkSite app on April 20 and is now available for download on the App Store and Google Play. This is the first app... Read More
Tuesday May 5, 2020
FDA expedites approval of Cochlear's Remote Check for cochlear implants
CENTENNIAL -- Cochlear Limited (ASX: COH), a leader in implantable hearing solutions, announced it has obtained U.S. Food and Drug Administration (FDA) approval for its Remote Check solution. The... Read More
Thursday April 9, 2020
Cell>Point to expedite research on new drugs as potentially effective theranostic technology in fight against COVID-19
CENTENNIAL -- CellPoint announced plans to move forward with a research program to clinically develop 99m Tc-EC-Amifostine and 177 Lu-EC-Amifostine to assess, treat and follow-up with confirmatory... Read More
Wednesday March 25, 2020
IN Sponsors
Browse
Entrepreneurial by Nature
